Pharmaceuticals and other health solutions developed by the modern healthcare system largely reflect a small subset of the global population — an overwhelming 86% of all clinical trial participants are of Caucasian origin though they make up only 16% of the world’s population.
With Mango Sciences, biotechnology, pharmaceutical, and clinical researchers finally have access to the diverse health information and real-world evidence needed to generate novel solutions and serve all patients.